Viki Bockstal

1.5k total citations
25 papers, 525 citations indexed

About

Viki Bockstal is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Viki Bockstal has authored 25 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 16 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Viki Bockstal's work include Viral Infections and Outbreaks Research (13 papers), Viral Infections and Vectors (7 papers) and Hepatitis B Virus Studies (7 papers). Viki Bockstal is often cited by papers focused on Viral Infections and Outbreaks Research (13 papers), Viral Infections and Vectors (7 papers) and Hepatitis B Virus Studies (7 papers). Viki Bockstal collaborates with scholars based in Netherlands, Belgium and United States. Viki Bockstal's co-authors include Stefan Magez, Macaya Douoguih, Kerstin Lühn, Cynthia Robinson, Dickson Anumendem, Samuel J. Black, Nathalie Geurts, Patrick Guirnalda, Georgi Shukarev and Magdalena Radwanska and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Journal of Virology.

In The Last Decade

Viki Bockstal

23 papers receiving 512 citations

Peers

Viki Bockstal
Alison Han United States
Karen Martins United States
Rodrigo I. Santos United States
Susan Reed United States
Rani Athota United States
Kaitlyn M. Morabito United States
Georgina Bowyer United Kingdom
Alison Han United States
Viki Bockstal
Citations per year, relative to Viki Bockstal Viki Bockstal (= 1×) peers Alison Han

Countries citing papers authored by Viki Bockstal

Since Specialization
Citations

This map shows the geographic impact of Viki Bockstal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viki Bockstal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viki Bockstal more than expected).

Fields of papers citing papers by Viki Bockstal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viki Bockstal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viki Bockstal. The network helps show where Viki Bockstal may publish in the future.

Co-authorship network of co-authors of Viki Bockstal

This figure shows the co-authorship network connecting the top 25 collaborators of Viki Bockstal. A scholar is included among the top collaborators of Viki Bockstal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viki Bockstal. Viki Bockstal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lacabaratz, Christine, Aurélie Wiedemann, Emile Foucat, et al.. (2024). Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial. The Journal of Infectious Diseases. 231(1). 230–240.
2.
Surénaud, Mathieu, Cynthia Robinson, Viki Bockstal, et al.. (2024). Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen. PLoS neglected tropical diseases. 18(4). e0011500–e0011500. 1 indexed citations
3.
Prague, Mélanie, Chelsea McLean, Viki Bockstal, et al.. (2023). Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola. npj Vaccines. 8(1). 174–174.
5.
Bockstal, Viki, Maarten Leyssen, Dirk Heerwegh, et al.. (2022). Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola. npj Vaccines. 7(1). 156–156. 13 indexed citations
6.
Bockstal, Viki, Auguste Gaddah, Neil Goldstein, et al.. (2021). Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen. npj Vaccines. 6(1). 157–157. 8 indexed citations
7.
Wagstaffe, Helen R., Elizabeth Clutterbuck, Viki Bockstal, et al.. (2020). Ebola virus glycoprotein stimulates IL-18–dependent natural killer cell responses. Journal of Clinical Investigation. 130(7). 3936–3946. 15 indexed citations
8.
Pasin, Chloé, Mélanie Prague, Fabien Crauste, et al.. (2020). A model for establishment, maintenance and reactivation of the immune response after vaccination against Ebola virus. Journal of Theoretical Biology. 495. 110254–110254. 11 indexed citations
9.
Trez, Carl De, Benoı̂t Stijlemans, Viki Bockstal, et al.. (2020). A Critical Blimp-1-Dependent IL-10 Regulatory Pathway in T Cells Protects From a Lethal Pro-inflammatory Cytokine Storm During Acute Experimental Trypanosoma brucei Infection. Frontiers in Immunology. 11. 1085–1085. 11 indexed citations
10.
Mutua, Gaudensia, Omu Anzala, Kerstin Lühn, et al.. (2019). Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya. The Journal of Infectious Diseases. 220(1). 57–67. 59 indexed citations
11.
Pasin, Chloé, Thierry Van Effelterre, Viki Bockstal, et al.. (2019). Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation. Journal of Virology. 93(18). 22 indexed citations
12.
Bockstal, Viki, Machteld M. Tiemessen, Ad M. Knaapen, et al.. (2018). An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model. Vaccine. 36(46). 6979–6987. 10 indexed citations
13.
Bockstal, Viki, et al.. (2018). A comparative study between outbred and inbred rat strains for the use in in vivo IPV potency testing. Vaccine. 36(21). 2917–2920. 3 indexed citations
14.
Zhang, Fengqiu, Patrick Guirnalda, Viki Bockstal, et al.. (2016). Trypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B Cells. PLoS Pathogens. 12(7). e1005733–e1005733. 31 indexed citations
15.
Bockstal, Viki, Taco G. Uil, Yutong Song, et al.. (2016). Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine. PLoS Pathogens. 12(3). e1005483–e1005483. 23 indexed citations
16.
Stijlemans, Benoı̂t, et al.. (2015). Development of a pHrodo-Based Assay for the Assessment of In Vitro and In Vivo Erythrophagocytosis during Experimental Trypanosomosis. PLoS neglected tropical diseases. 9(3). e0003561–e0003561. 29 indexed citations
17.
Bockstal, Viki, Patrick Guirnalda, Guy Caljon, et al.. (2011). T. brucei Infection Reduces B Lymphopoiesis in Bone Marrow and Truncates Compensatory Splenic Lymphopoiesis through Transitional B-Cell Apoptosis. PLoS Pathogens. 7(6). e1002089–e1002089. 59 indexed citations
18.
Bockstal, Viki, Nathalie Geurts, & Stefan Magez. (2011). Acute Disruption of Bone Marrow B Lymphopoiesis and Apoptosis of Transitional and Marginal Zone B Cells in the Spleen following a Blood-StagePlasmodium chabaudiInfection in Mice. Journal of Parasitology Research. 2011. 1–11. 37 indexed citations
19.
Stijlemans, Benoı̂t, Guy Caljon, Viki Bockstal, et al.. (2010). The Central Role of Macrophages in Trypanosomiasis-Associated Anemia:Rationale for Therapeutical Approaches. Endocrine Metabolic & Immune Disorders - Drug Targets. 10(1). 71–82. 24 indexed citations
20.
Black, Samuel J., et al.. (2009). Induction and regulation ofTrypanosoma bruceiVSG-specific antibody responses. Parasitology. 137(14). 2041–2049. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026